Ro KhannaSell
IDXX Common Stock · Transaction Jun 30, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · IDXX
+1.96% · +$10.68 · Vol 512.6K
Market closed · last close 4:00 PM ET · price as of 18:07:27 ET
IDEXX Laboratories Inc
Health Care
$555.00
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Jul 27 · market closed · Markets closed · resumes Tue 9:30 ET · IDXX
MethodologyIDXX
IDEXX Laboratories Inc
Mon Jul 27 · market closed · Markets closed · resumes Tue 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
48/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Jul 27 · market closed · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is IDXX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About IDEXX Laboratories Inc
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESListed since
1991
Employees
11K
Country
US
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$550.77
Day high
$563.86
Day low
$548.00
Previous close
$544.32
52W high
$766.68
-27.61% from high
52W low
$526.44
12% of range
Market cap
$42.9B
P/E
43.94×
EPS
$12.63
Beta
0.71
Shares out
78.9M
Volume
512.6K
0.77× rel vol
Avg volume
663.3K
VWAP
$556.94
Price history computed in-house
1W
+0.46%
1M
+0.63%
3M
+0.24%
1Y
-2.03%
YTD
-17.96%
SMA 50 $555.04 · below
SMA 200 $621.76 · below
52W position 12%
IDXX overview
Related filings and maps
Public disclosures
Congress activity in IDXX
Official filing ↗
Ro KhannaBuy
IDXX · Transaction May 27, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Ro KhannaSell
IDXX Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Ro KhannaSell
IDXX Common Stock · Transaction May 1, 2026 · Filed Jun 9, 2026 · Amount pending receipt enrichment
Ro KhannaBuy
IDXX Common Stock · Transaction Apr 13, 2026 · Filed May 11, 2026 · Amount pending receipt enrichment
Federal contracts
IDXX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IDXX in this window.
Lobbying spend
IDXX lobbying filings, year to date.
Registered lobbying filings matched to IDEXX Laboratories Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IDXX in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for IDXX.
Options
Sovereign unlock shows live options positioning for IDXX.